星裕太 (Yuta Hoshi) - マイポータル

基本情報

所属: 国立研究開発法人国立がん研究センター頭頸部内科

研究者番号: 60846583
J-GLOBAL ID: 202101013351369068
researchmap会員ID: R000029649

研究分野

ライフサイエンス / 腫瘍診断、治療学 /

論文

Intracranial antitumor efficacy of combination treatment with encorafenib plus binimetinib in BRAF V600E-mutated anaplastic thyroid carcinoma

Ryutaro Onaga, Tomohiro Enokida, Toshifumi Tomioka, Shingo Sakashita, Masanobu Sato, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa …

Auris Nasus Larynx 53(1) 7-12 2026年2月
LH–RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study

Takuma Kishida, Tomohiro Enokida, Ryutaro Onaga, Nobukazu Tanaka, Yuta Hoshi, Takao Fujisawa, Ryo Kuboki, Hideki Tanaka, Susumu Okano, Makoto Tahara

International Journal of Clinical Oncology 2025年6月24日
Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan

Ryutaro Onaga, Tomohiro Enokida, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Masanobu Sato, Naohiro Takeshita, Hideki Tanaka, Takao Fujisawa …

Thyroid® 2025年6月9日
Prognostic impact of preoperative imaging-detected extranodal extension in head and neck squamous cell carcinoma treated with postoperative chemoradiotherapy.

Yuta Hoshi, Hirofumi Kuno, Shingo Sakashita, Takashi Hiyama, Ryutaro Onaga, Susumu Okano, Tomohiro Enokida, Takao Fujisawa, Nobukazu Tanaka, Takuma Kishida …

Journal of Clinical Oncology 43(16_suppl) 6063-6063 2025年6月
Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy

Ryutaro Onaga, Tomohiro Enokida, Hirofumi Kuno, Takashi Hiyama, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki …

Oral Oncology 165 107351-107351 2025年6月
切除不能局所進行嗅神経芽細胞腫に対する導入化学療法と陽子線治療による非外科的根治治療の後方視的検討

久保木諒, 榎田智弘, 田中伸和, 岡野晋, 藤澤孝夫, 翁長龍太郎, 星裕太, 岸田拓磨, 藤澤建志, 全田貞幹 …

頭頸部癌 51(2) 161-161 2025年5月
術後化学放射線治療を要した頭頸部扁平上皮癌における術前の画像的リンパ節節外浸潤の意義に関する検討

星裕太, 久野博文, 坂下信悟, 檜山貴志, 翁長龍太郎, 岡野晋, 榎田智弘, 藤澤孝夫, 田中伸和, 岸田拓磨 …

頭頸部癌 51(2) 187-187 2025年5月
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer

Ryutaro Onaga, Tomohiro Enokida, Shingo Sakashita, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa, Susumu Okano, Hiroshi Nishino …

International Journal of Clinical Oncology 2025年4月10日
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer.

Ryutaro Onaga, Tomohiro Enokida, Shingo Sakashita, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Ryo Kuboki, Takao Fujisawa, Susumu Okano, Hiroshi Nishino …

International journal of clinical oncology 2025年4月10日
Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)

Nobukazu Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Hideki Tanaka, Ryutaro Onaga, Yuta Hoshi, Takuma Kishida, Akihisa Wada, Masanobu Sato …

Oral Oncology 163 107235-107235 2025年4月
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.

Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Hideki Tanaka, Masanobu Sato, Naohiro Takeshita …

International journal of clinical oncology 29(10) 1435-1443 2024年10月
Significance of imaging-detected extranodal extension (iENE) in locally advanced head and neck squamous cell carcinoma (LASCCHN) treated with induction chemotherapy followed by chemoradiotherapy.

Ryutaro Onaga, Tomohiro Enokida, Takashi Hiyama, Nobukazu Tanaka, Yuta Hoshi, Hideki Tanaka, Takao Fujisawa, Susumu Okano, Hirofumi Kuno, Makoto Tahara

Journal of Clinical Oncology 42(16_suppl) 6034-6034 2024年6月1日
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.

Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Mayuko Izumi, Tomoki Kuge, Maiko Naito, Yumiko Mizuno, Yuta Yamaguchi …

JCI insight 9(3) 2024年2月8日
Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma.

Yuta Hoshi, Tomohiro Enokida, Shingo Tamura, Torahiko Nakashima, Susumu Okano, Takao Fujisawa, Masanobu Sato, Akihisa Wada, Hideki Tanaka, Naohiro Takeshita …

Frontiers in oncology 14 1379013-1379013 2024年筆頭著者
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Nobukazu Tanaka, Ryutaro Onaga, Yuta Hoshi …

Oral oncology 147 106615-106615 2023年12月
MO43-1 The treatment sequence of weekly paclitaxel, carboplatin, and cetuximab (PCE) followed by nivolumab for R/M SCCHN

Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Satou, Hideki Tanaka, Nobukazu Tanaka, Ryutaro Onaga, Yuta Hoshi …

Annals of Oncology 34 S1424-S1424 2023年11月
頭頸部扁平上皮がんに対するニボルマブ単剤治療の多重免疫染色を用いたバイオマーカー探索(Investigation of biomarkers by multiplex immunohistochemistry for nivolumab monotherapy in SCCHN)

星裕太, 榎田智弘, 奥村元紀, 田中伸和, 岡野晋, 藤澤孝夫, 竹下直宏, 翁長龍太郎, 小山正平, 坂下信悟 …

日本癌学会総会記事 82回 426-426 2023年9月
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab.

Yuta Hoshi, Satoshi Shirakura, Masato Yamada, Tomonori Sugiyama, Nobuaki Koide, Satoru Tamii, Kyohei Kamata, Masaru Yokomura, Sotaro Osaki, Takafumi Ohno …

International journal of clinical oncology 28(9) 1139-1146 2023年9月筆頭著者
Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin.

Ryutaro Onaga, Tomohiro Enokida, Kazue Ito, Yuri Ueda, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Naohiro Takeshita …

Frontiers in oncology 13 1185198-1185198 2023年
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.

Hideki Tanaka, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Naohiro Takeshita, Ryutaro Onaga, Yuta Hoshi, Akihisa Wada, Masanobu Sato …

Frontiers in oncology 13 1221352-1221352 2023年

もっとみる

MISC

421P Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)

N. Tanaka, T. Enokida, S. Okano, T. Fujisawa, R. Onaga, Y. Hoshi, H. Tanaka, A. Wada, M. Sato, N. Takeshita …

Annals of Oncology 35 S1561-S1561 2024年12月
Investigation of biomarkers by multiplex immunohistochemistry for nivolumab monotherapy in SCCHN

Yuta Hoshi, Tomohiro Enokida, Genki Okumura, Nobukazu Tanaka, Susumu Okano, Takao Fujisawa, Naohiro Takeshita, Ryutaro Onaga, Shohei Koyama, Shingo Sakashita …

CANCER SCIENCE 115 426-426 2024年3月
頭頸部がん診療のControversy 導入化学療法どっちを選ぶ?TPF vs PCE PCE

星裕太, 岡野晋

耳鼻咽喉科・頭頚部外科 96(4) 2024年
Salvage chemotherapy with paclitaxel plus cetuximab (PE)based regimen following immune checkpoint inhibitor in R/M SCCHN

Hideki Tanaka, Tomohiro Enokida, Susumu Okano, Yuri Ueda, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Naohiro Takeshita, Nobukazu Tanaka, Ryutoro Onaga …

ANNALS OF ONCOLOGY 34 S1388-S1388 2023年11月
Long-term clinical outcomes of Lenvatinib in patients with differentiated thyroid cancer: Results from the real-world practice of a single institution

R. Onaga, T. Enokida, S. Okano, T. Fujisawa, H. Tanaka, N. Takeshita, N. Tanaka, Y. Hoshi, M. Tahara

Annals of Oncology 34 S1147-S1147 2023年10月

星裕太

基本情報

研究分野

論文

MISC

所属学協会

メニュー